MG
VCYT icon

Michael Gelband’s Veracyte VCYT Stock Holding History

Michael Gelband’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,300
Closed -$1.61M – 2643
2020
Q4 		$1.61M Buy
+32,300
New +$1.5M 0.02% 632

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Michael Gelband's VCYT Position: Q2 2026 in Review

Michael Gelband opened a new position in Veracyte (VCYT) in Q2 2026: 94,044 shares worth $5.52M. The stake represents 0.04% of the portfolio and ranks #461 among its holdings. This is a return to the name: Michael Gelband previously reported a position in VCYT as recently as Q4 2025.

Michael Gelband first reported a position in VCYT in Q4 2020 and has held it in 14 quarters since. The position peaked at $25M in Q3 2024. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Michael Gelband held 94,044 shares of Veracyte worth $5.52M as of Q2 2026.
  • Veracyte was a new Michael Gelband position in Q2 2026.
  • Veracyte made up 0.04% of Michael Gelband's portfolio in Q2 2026, its #461 holding.
  • Michael Gelband first reported a position in Veracyte in Q4 2020 and has held it in 14 quarters since.
  • Michael Gelband's Veracyte position peaked at $25M in Q3 2024.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.